SCHEMBL738703

SCHEMBL738703

COCCCn1c([C@@H]2CCCN(C(=O)C[C@@H](Cc3ccc4ccccc4c3)NC(=O)O)C2)nc2c(OC)cccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.36
KCNH2 Q12809 3/20 0.36
HRH1 P35367 3/20 0.36
CYP2D6 P10635 2/20 0.36
ALDH1A1 P00352 4/20 0.35
TSHR P16473 2/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
CHRM1 P11229 1/20 0.35
TACR2 P21452 1/20 0.34
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
USP2 O75604 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10293032 0.92 PADI4 (0.37) TACR1KCNH2HRH1CYP2D6KMT2A
SCHEMBL738775 0.90 CFD (0.38) KCNH2HRH1CYP2D6ALDH1A1TSHR
SCHEMBL738776 0.90 CFD (0.38) KCNH2HRH1CYP2D6ALDH1A1TSHR
SCHEMBL739901 0.90 HRH1 (0.46) KCNH2HRH1CYP2D6CHRM1USP2
SCHEMBL739252 0.87 KCNH2 (0.41) KCNH2HRH1CYP2D6ALDH1A1TSHR
SCHEMBL742275 0.86 HRH1 (0.42) TACR1KCNH2HRH1CYP2D6CHRM1
SCHEMBL739598 0.86 HRH1 (0.35) KCNH2HRH1CYP2D6ALDH1A1TSHR
SCHEMBL740708 0.86 HRH1 (0.39) TACR1KCNH2HRH1CYP2D6ALDH1A1
SCHEMBL10293031 0.86 PADI4 (0.38) KCNH2HRH1CYP2D6ALDH1A1TSHR
SCHEMBL740857 0.85 KCNH2 (0.39) KCNH2HRH1CYP2D6CHRM1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed